Walleye Trading’s Travere Therapeutics TVTX Stock Holding History

Walleye Trading’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Buy	+2,000	New	+$88.7K	﹤0.01%	3360
2026 Q1	–	Sell	-9,900	Closed	-$378K	–	4740
2025 Q4	$378K	Sell	9,900 -14,100	-59%	-$458K	﹤0.01%	3003
2025 Q3	$574K	Buy	+24,000	New	+$451K	﹤0.01%	2648
2022 Q1	–	Sell	-500	Closed	-$16K	–	5930
2021 Q4	$16K	Buy	+500	New	+$14.1K	﹤0.01%	4995
2021 Q1	–	Sell	-5,900	Closed	-$161K	–	5314
2020 Q4	$161K	Buy	+5,900	New	+$138K	﹤0.01%	3664
2020 Q3	–	Sell	-9,300	Closed	-$190K	–	4635
2020 Q2	$190K	Buy	+9,300	New	+$148K	﹤0.01%	3107
2019 Q4	–	Sell	-24,000	Closed	-$278K	–	4648
2019 Q3	$278K	Buy	+24,000	New	+$397K	﹤0.01%	2657
2019 Q1	–	Sell	-7,800	Closed	-$177K	–	4785
2018 Q4	$177K	Sell	7,800 -27,400	-78%	-$682K	﹤0.01%	3497
2018 Q3	$1.01M	Buy	+35,200	New	+$1.01M	0.01%	2053
2018 Q1	–	Sell	-22,400	Closed	-$470K	–	4813
2017 Q4	$470K	Buy	+22,400	New	+$512K	﹤0.01%	2663

Other funds holding TVTX

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Trading's TVTX Position: Q2 2026 in Review

Walleye Trading opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 1,901 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #3376 among its holdings. This is a return to the name: Walleye Trading previously reported a position in TVTX as recently as Q4 2025.

Walleye Trading first reported a position in TVTX in Q2 2015 and has held it in 18 quarters since. The position peaked at $785K in Q3 2022. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

Walleye Trading held 1,901 shares of Travere Therapeutics worth $108K as of Q2 2026.
Travere Therapeutics was a new Walleye Trading position in Q2 2026.
Travere Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3376 holding.
Walleye Trading first reported a position in Travere Therapeutics in Q2 2015 and has held it in 18 quarters since.
Walleye Trading's Travere Therapeutics position peaked at $785K in Q3 2022.
320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.